356 related articles for article (PubMed ID: 33179141)
21. Tumor microenvironment derived signature predicting relapse-free survival in I-III cancer and preliminary experiment verification.
Zhang Z; Wu Q; Zhu D; He G; Feng Q; Xu J
Int Immunopharmacol; 2021 Feb; 91():107243. PubMed ID: 33321467
[TBL] [Abstract][Full Text] [Related]
22. Exploration of the immune cell infiltration-related gene signature in the prognosis of melanoma.
Zeng Y; Zeng Y; Yin H; Chen F; Wang Q; Yu X; Zhou Y
Aging (Albany NY); 2021 Jan; 13(3):3459-3482. PubMed ID: 33428606
[TBL] [Abstract][Full Text] [Related]
23. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
Wang Z; Tu L; Chen M; Tong S
BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
[TBL] [Abstract][Full Text] [Related]
24. Characteristics and significance of programmed cell death-related gene expression signature in skin cutaneous melanoma.
Wu X; Chen S; Ji Q; Chen H; Chen X
Skin Res Technol; 2024 May; 30(5):e13739. PubMed ID: 38766879
[TBL] [Abstract][Full Text] [Related]
25. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
Ren N; Liang B; Li Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
[TBL] [Abstract][Full Text] [Related]
26. Identification of prognostic genes and construction of a novel gene signature in the skin melanoma based on the tumor microenvironment.
Yingjuan W; Li Z; Wei C; Xiaoyuan W
Medicine (Baltimore); 2021 May; 100(21):e26017. PubMed ID: 34032721
[TBL] [Abstract][Full Text] [Related]
27. Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma.
Liu D; Yang X; Wu X
Front Immunol; 2021; 12():663495. PubMed ID: 34025664
[TBL] [Abstract][Full Text] [Related]
28. Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanoma.
Wu Z; Zhang R; Bao J; Yin M; Wang X
Arch Dermatol Res; 2024 May; 316(6):219. PubMed ID: 38787413
[TBL] [Abstract][Full Text] [Related]
29. A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma.
Mei Y; Chen MM; Liang H; Ma L
Commun Biol; 2021 Mar; 4(1):383. PubMed ID: 33753855
[TBL] [Abstract][Full Text] [Related]
30. A novel immune-related prognostic index for predicting breast cancer overall survival.
Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
[TBL] [Abstract][Full Text] [Related]
31. A Novel Signature of 23 Immunity-Related Gene Pairs Is Prognostic of Cutaneous Melanoma.
Xue YN; Xue YN; Wang ZC; Mo YZ; Wang PY; Tan WQ
Front Immunol; 2020; 11():576914. PubMed ID: 33193373
[TBL] [Abstract][Full Text] [Related]
32. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
[TBL] [Abstract][Full Text] [Related]
34. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.
Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H
Front Immunol; 2021; 12():657950. PubMed ID: 33936088
[TBL] [Abstract][Full Text] [Related]
35. PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM).
Zhang S; Chen K; Liu H; Jing C; Zhang X; Qu C; Yu S
J Immunother; 2021 Jul-Aug 01; 44(6):214-223. PubMed ID: 34028390
[TBL] [Abstract][Full Text] [Related]
36. Determination of hypoxia signature to predict prognosis and the tumor immune microenvironment in melanoma.
Shou Y; Yang L; Yang Y; Zhu X; Li F; Xu J
Mol Omics; 2021 Apr; 17(2):307-316. PubMed ID: 33624645
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients.
Yuan Y; Zhu Z; Lan Y; Duan S; Zhu Z; Zhang X; Li G; Qu H; Feng Y; Cai H; Song Z
Front Immunol; 2021; 12():659444. PubMed ID: 34040608
[TBL] [Abstract][Full Text] [Related]
38. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
Lei S; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166
[TBL] [Abstract][Full Text] [Related]
39. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
40. Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature.
Yang Y; Long X; Li G; Yu X; Liu Y; Li K; Tian X
Bioengineered; 2021 Dec; 12(1):1803-1812. PubMed ID: 34047683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
